STVN: Stevanato Group Corp Market Valuation

Stevanato Group S.p.A. (STVN) operates in the medical equipment sector. This chart of market capitalization history, which currently stands at 0.79, demonstrates the asset's price action. The business remains vulnerable due to a declining demand for immunizing agents and raw material price volatility. Revenue is generated through the production of complex containers for biologics and insulin systems. Growth is driven by a shortage of specialized vials amid the hype surrounding weight-loss drugs.

STVN Stevanato Group: Market Capitalization in the range 07/04/2022 - 11/14/2026

STVN (Stevanato Group Corp): analytical breakdowns and indicator data

- stock price and consensus target price:

Stock Quotes Stevanato Group|STVN - Analyst Forecast Prices

- market capitalization information:

Market Valuation Stevanato Group Corp|STVN - Total Company Value

- business book valuation details:

Net Assets per Single Share Stevanato Group|STVN - Accounting Capitalization|Market Value to Book Value Ratio stevanatogroup.com|STVN - Cumulative Company Assets

- business debt structure and liquidity details:

- business earnings and investment ratios data:

STVN - Net Profit|Expected Profit Stevanato Group S.p.A.|STVN - Price to Earnings Ratio|Projected Price to Earnings Stevanato|STVN - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Stevanato Group Corp|STVN - Operating income before deduction of amortization|Earnings per share for the last twelve months Stevanato Group|STVN - Earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months stevanatogroup.com|STVN - Expected net earnings per share growth this year|Expected earnings per share growth for next year Stevanato Group S.p.A.

- sales and revenue indicators:

STVN - Company Total Sales|Company Projected Revenue Stevanato Group|STVN - Market Capitalization-to-Revenue Ratio|Forward Price-to-Revenue Multiple Stevanato Group Corp

Fundamental company valuation:Stevanato Group STVN

The monopolization of the premium packaging market for biologics and mRNA vaccines positions Stevanato Group S.p.A. (STVN) as a strategic partner for pharmaceutical behemoths, which directly impacts the business's market valuation. When analyzing the issuer's exchange value, an investor sees the aggregate market capitalization, which instantly prices in market expectations and reactions to corporate events, allowing for the differentiation of fundamental growth from the speculative risks of this asset.

Analysis of competing companies